The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
September 23rd 2023
Results from both studies showed the safety of filgotinib for the treatment of ulcerative colitis compared to placebo treatment groups.
September 21st 2023
September 20th 2023
BURST CME™: Utilizing Pathology Reports to Inform Treatment Plans Across GI Cancers
View More
20th Annual Meeting of the International Society of Gastrointestinal Oncology®
Register Now!
2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers
View More
Medical Crossfire®: Multidisciplinary Strategies to Leverage Clinical Advances on Immune-Based Therapies for Patients with Hepatocellular Carcinoma
View More
2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers
View More
Oncology Town Hall™: Primary Investigators Present Key Abstracts in Gastrointestinal Malignancies from Paris
View More
Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®
View More
Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers
View More
Community Practice Connections: Optimizing Recognition and Management of Acute Hepatic Porphyria
View More
Virtual Tumor Board®: Optimizing HER2 Testing Strategies for Clinical Decision Making in GI Malignancies
View More
Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow
View More
Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
View More
Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care
View More
9th Annual School of Gastrointestinal Oncology® (SOGO®)
Register Now!
Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World of Clinical Trials in Cholangiocarcinoma Treatment
View More
4th Annual Live Medical Crossfire® IBS and IBD
View More
Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C
View More
Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Bridging Precision Medicine Techniques and Emerging Treatments in Metastatic Colorectal Cancer
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Rapid Oncology Abstract Review®: Key Updates in Gastrointestinal Cancers from the ASCO Annual Meeting
View More
Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®
View More
Expert Illustrations and Commentaries™: Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice
View More
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Oncology Town Hall: Live Report from Barcelona for Advances in the Treatment of GI Cancers
View More
Importance of Colorectal Cancer Screening, with Jordan Baeker Bispo, PhD, MPH
September 18th 2023Jordan Baeker Bispo, PhD, MPH, discusses the importance of colorectal cancer screening, why clinician screening recommendations are so important, and how patient-clinician communication gaps should be addressed.
Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
September 16th 2023Survey results showed patients with a history of live biotherapeutic product therapy preferred rectally administered treatment while patients who had not received live biotherapeutic product therapy would be willing to consider it.
Study Finds Only 1 in 4 Get Colorectal Cancer Screening Recommendation
September 11th 2023Investigators called attention to low patient-reported levels of clinician recommendation for colorectal cancer screening during wellness visits, noting the prevalence was lowest among those without insurance and without a usual source of care.
Handgrip Strength, Other Factors Could Signal Increased Hospitalization Risk in IBD
September 11th 2023Results from the study found independent associations between handgrip strength, abPG-SGA, and SaskIBD-NRT with risk of IBD-related hospitalization, further noting clinical frailty scale and subjective global assessment were not associated with risk of hospitalization.
DAA Treatment Improves Liver Function, Increases Risk of Anemia in Patients With HCV, Study Finds
September 11th 2023Investigators noted improved liver function, increased prevalence of anemia, and decreased hemoglobin concentration, hematocrit index, and estimated glomerular filtration rate among patients with HCV after 12 weeks of DAA treatment.
Fidaxomicin, Oral Metronidazole Demonstrate Similar Clinical Efficacy Among Patients With C Diff
September 7th 2023Patients with CDI treated with oral metronidazole experienced significantly more first-line drug changes compared to those on fidaxomicin, although there were no significant differences observed in the global or clinical cure rate between the two treatments.
Vedolizumab Not Associated With Increased Risk of C Diff in Patients With IBD, Study Finds
September 6th 2023Vedolizumab, anti-TNF, and 5-ASA treatments were not linked to an increased risk of CDI, but investigators noted other baseline variables were significantly associated with CDI risk in patients with IBD.
Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD
September 5th 2023The clinical trial compared outcomes in patients with NAFLD on a resistant starch diet to a control group over a 4-month period, with results suggesting microbiota dietary supplements may improve liver conditions.
HCV-Infected Liver Transplant Patients Benefit from DAA Use, Study Finds
September 2nd 2023Results from the retrospective cohort study indicated viral eradication with DAAs after liver transplantation improved liver function and patient survival after a long-term follow-up, even in cirrhotic patients.
Biden Administration, CMS Reveal First 10 Drugs Set for Price Negotiation
August 29th 2023On August 29, 2023, the Biden Administration debuted the list of the first 10 drugs identified for price negotiation under the Inflation Reduction Act. The list, which includes agents indicated for diabetes, heart failure, GI conditions, and arthritis, accounted for more than $50 billion in spending during the evaluation period.
AbbVie Submits Application to FDA for Risankizumab in Ulcerative Colitis
August 28th 2023AbbVie submitted regulatory applications to the FDA and EMA for rizankizumab 1200 mg intravenous induction dose and 180 mg and 360 mg subcutaneous maintenance dose following successful Phase 3 trials INSPIRE and COMMAND.
Age, Prior Vaccination Predict Future Vaccine Receipt in Patients with IBD
August 24th 2023When evaluating patient-education strategies among individuals with IBD, investigators found vaccine uptake was unaffected by educational videos and text-based interventions, identifying prior vaccine receipt as the strongest predictor of future vaccination.